SCHEMBL5485920

SCHEMBL5485920

Cc1nc(N2CCCC2)c2ccc(Nc3ccc(C#N)cc3)cc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
HRH4 Q9H3N8 2/20 0.46
HSD17B10 Q99714 5/20 0.42
ALDH1A1 P00352 4/20 0.42
MAPT P10636 4/20 0.42
NPSR1 Q6W5P4 4/20 0.42
ALOX15 P16050 3/20 0.42
TSHR P16473 3/20 0.42
KDM4E B2RXH2 3/20 0.42
CASP1 P29466 2/20 0.42
CASP7 P55210 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
USP2 O75604 1/20 0.42
KIT P10721 1/20 0.42
PRKDC P78527 1/20 0.42
MAPK1 P28482 2/20 0.40
LMNA P02545 3/20 0.39
RECQL P46063 3/20 0.39
HTT P42858 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5486783 0.84 KMT2A (0.51) KMT2AMEN1HSD17B10ALDH1A1MAPT
SCHEMBL5026895 0.81 NCF1 (0.51) KMT2AMEN1ALDH1A1MAPTNPSR1
SCHEMBL5494681 0.81 MEN1 (0.48) KMT2AMEN1HRH4HSD17B10ALDH1A1
Hydrochloric Acid SCHEMBL5493398 0.81 MEN1 (0.50) KMT2AMEN1HRH4HSD17B10ALDH1A1
SCHEMBL22911938 0.80 MEN1 (0.57) KMT2AMEN1HSD17B10KDM4EL3MBTL1
SCHEMBL5492423 0.78 PIK3CA (0.56) KMT2AMEN1HSD17B10ALDH1A1MAPT
SCHEMBL5486974 0.77 MAOB (0.47) KMT2AMEN1HRH4KDM4EPRKDC
SCHEMBL5412855 0.77 CYP1A2 (0.53) KMT2AMEN1HRH4ALDH1A1TSHR
SCHEMBL5489231 0.74 MEN1 (0.50) KMT2AMEN1HSD17B10L3MBTL1MAPK1
SCHEMBL5485963 0.74 MEN1 (0.50) KMT2AMEN1HSD17B10L3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205309-B2 Quinazoline derivatives HOFFMANN-LA ROCHE INC. (US) 2007-04-17 US disclosed
US-20040029901-A1 Quinazoline derivatives HOFFMANN-LA ROCHE INC. 2004-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029901-A1 Quinazoline derivatives GPR119, NQO2, CYP7A1 KMT2A 1664/4885MEN1 1326/4885HRH4 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.